Guelph, Canada

David Miller

This inventor holds 1 USPTO granted patent, plus 2 CIPO patents and 1 EPO patent. Top assignee: Evolve Biologics Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Miller. Retrieved from https://idiyas.com/inventor/david-miller-5fgza588

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Miller - Innovator in Chromatography

Introduction: David Miller is an accomplished inventor based in Guelph, Canada. He is currently associated with Evolve Biologics Inc., where he contributes to advancements in biotechnological applications. Despite having no granted patents to his name, his work in the field of chromatography is noteworthy.

Latest Patent Applications: David Miller's latest patent application is titled "Modified Column for Expanded Bed Adsorption and Methods of Use Thereof." This application presents chromatography columns and methods of chromatographic separation. Specifically, it details modified columns where the cross-sectional area increases in a flared manner near the end of the column. These modified columns are designed for use in Expanded Bed Absorption (EBA) systems, showcasing innovative approaches to enhance separation techniques.

Conclusion: David Miller's contributions to the field of chromatography, particularly through his latest patent application, highlight his commitment to innovation in biotechnological processes. His work at Evolve Biologics Inc. positions him as a significant figure in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…